Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Standard Dose
25MG;EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 201356 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 25MG;EQ 20MG BASE Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2022-05-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 201356 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 25MG;EQ 20MG BASE Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2022-05-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.